Mysoline Tablet
Product Images NDC 66490-690

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mysoline (NDC 66490-690). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bausch Health Us, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

250mg.jpg (250mg)

Mysoline (primidone) tablets USP, 250 mg strength, oral tablets, packaged in a container of 100 tablets. The label shows it is an anticonvulsant drug labeled for prescription use only, manufactured by Bausch Health US, LLC. Storage instructions and pharmacist dispensing guidance are included on the label.*

FDA Label Image

50mg.jpg (50mg)

Mysoline 50 mg tablets, USP oral anticonvulsant by Bausch Health US, LLC. Packaging label for a bottle containing 100 tablets. Label includes dosage strength, NDC 66490-690-10, storage instructions (20° to 25°C), pharmacist dispensing guidance, and child-resistant container warning. Barcode and labeler information also visible.*

FDA Label Image

Chemical Structure (Mysoline 01)

Chemical structure of primidone showing its molecular formula C12H14N2O2 and molecular weight 218.25.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.